Financial Synergies Wealth Advisors, Inc. Organon & Co. Transaction History

Financial Synergies Wealth Advisors, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 12, 2024	BUY	$13.78 - $18.8 $248 - $338	18 Added 33.96%	71 $1.34 Million
Q4 2023 Apr 04, 2024	SELL	$10.95 - $17.32 $98 - $155	-9 Reduced 14.52%	53 $1.48 Million
Q2 2023 Apr 04, 2024	BUY	$19.27 - $24.63 $809 - $1,034	42 Added 210.0%	62 $1.29 Million
Q1 2023 Apr 04, 2024	SELL	$21.42 - $32.08 $706 - $1,058	-33 Reduced 62.26%	20 $471,000
Q4 2022 Apr 04, 2024	BUY	$23.31 - $28.61 $769 - $944	33 Added 165.0%	53 $1.48 Million
Q2 2022 Apr 04, 2024	BUY	$31.66 - $38.9 $633 - $778	20 New	20 $675,000

809

207M

1.19M

910K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.89B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Financial Synergies Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Financial Synergies Wealth Advisors, Inc. with notifications on news.